4.4 Article

Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects

期刊

OPHTHALMOLOGY AND THERAPY
卷 11, 期 4, 页码 1463-1477

出版社

SPRINGER INT PUBL AG
DOI: 10.1007/s40123-022-00522-x

关键词

Absorption; Bioavailability; Carotenoids; Lutein; Macular pigment optical density; Zeaxanthin

资金

  1. OmniActive Health Technologies Limited (Mumbai, India)

向作者/读者索取更多资源

The study demonstrates that our novel LZO formulation has superior bioavailability for lutein and zeaxanthin compared to the LZC formulation. This enhanced bioavailability can be advantageous for individuals wishing to quickly improve their levels of L and Z and enhance their vision performance.
Introduction: Lutein (L) and zeaxanthin (Z) are carotenoids that are found in the macula of the human eye and are known to improve visual functions. However, poor bioavailability of supplemental L and Z poses a challenge to achieving significant benefits after consumption. We developed a novel patented formulation of L and Z (Ocusorb (R)) and demonstrated the improved bioavailability in a pharmacokinetic clinical study. Methods: Ninety adult human volunteers were recruited in this randomized, double-blind, parallel, comparative bioavailability study. Volunteers were randomly assigned to receive single dose of 10 mg lutein and 2 mg zeaxanthin from test (LZO) or reference (LZC) formulations after breakfast. Blood samples were collected pre-dose at - 48, - 24, and 0 h and at 2, 4, 6, 8, 10, 12, 16, 20, 24, 48, and 72 h post-dose. Serum concentrations of L and Z were quantified by using a validated HPLC method. The LZO and LZC formulations were compared for L and Z on the basis of C-max, AUC(0-)(72), and AUC(0-t). Results: All 90 subjects completed the study. The LZO group demonstrated significantly higher levels of L and Z in serum at several time points as compared to LZC group. The LZO group showed significantly higher bioavailability for lutein (2.5 times higher C-max, 2.9 times higher AUC(0-)(72), and 3.2 times higher AUC(0-t)) and zeaxanthin (1.8 times higher C-max, 2.2 times higher AUC(0-)(72), and AUC(0-t)) as compared to the LZC group. No safety issues were reported. Conclusion: The study results show superior bioavailability of lutein and zeaxanthin from our novel LZO formulation as compared to LZC. The enhanced bioavailability from the LZO formulation can be advantageous for individuals looking to quickly improve their L and Z status and enhance their vision performance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据